2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase

被引:52
作者
Walsh, Martin J. [1 ]
Brimacombe, Kyle R. [1 ]
Veith, Henrike [1 ]
Bougie, James M. [1 ]
Daniel, Thomas [1 ]
Leister, William [1 ]
Cantley, Lewis C. [2 ,3 ]
Israelsen, William J. [4 ]
Vander Heiden, Matthew G. [4 ,5 ]
Shen, Min [1 ]
Auld, Douglas S. [1 ]
Thomas, Craig J. [1 ]
Boxer, Matthew B. [1 ]
机构
[1] NHGRI, NIH Chem Genom Ctr, NIH Ctr Translat Therapeut, NIH, Rockville, MD 20850 USA
[2] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA
[4] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
PKM2; Pyruvate kinase; Cellular metabolism; Anti-cancer strategies; Small molecule activators; GENE; RAT; ISOZYMES; GROWTH; SYSTEM;
D O I
10.1016/j.bmcl.2011.08.114
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Compared to normal differentiated cells, cancer cells have altered metabolic regulation to support biosynthesis and the expression of the M2 isozyme of pyruvate kinase (PKM2) plays an important role in this anabolic metabolism. While the M1 isoform is a highly active enzyme, the alternatively spliced M2 variant is considerably less active and expressed in tumors. While the exact mechanism by which decreased pyruvate kinase activity contributes to anabolic metabolism remains unclear, it is hypothesized that activation of PKM2 to levels seen with PKM1 may promote a metabolic program that is not conducive to cell proliferation. Here we report the third chemotype in a series of PKM2 activators based on the 2-oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamide scaffold. The synthesis, structure activity relationships, selectivity and notable physiochemical properties are described. Published by Elsevier Ltd.
引用
收藏
页码:6322 / 6327
页数:6
相关论文
共 17 条
[1]   Evaluation of Substituted N,N′-Diarylsulfonamides as Activators of the Tumor Cell Specific M2 Isoform of Pyruvate Kinase [J].
Boxer, Matthew B. ;
Jiang, Jian-kang ;
Vander Heiden, Matthew G. ;
Shen, Min ;
Skoumbourdis, Amanda P. ;
Southall, Noel ;
Veith, Henrike ;
Leister, William ;
Austin, Christopher P. ;
Park, Hee Won ;
Inglese, James ;
Cantley, Lewis C. ;
Auld, Douglas S. ;
Thomas, Craig J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) :1048-1055
[2]   The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth [J].
Christofk, Heather R. ;
Vander Heiden, Matthew G. ;
Harris, Marian H. ;
Ramanathan, Arvind ;
Gerszten, Robert E. ;
Wei, Ru ;
Fleming, Mark D. ;
Schreiber, Stuart L. ;
Cantley, Lewis C. .
NATURE, 2008, 452 (7184) :230-U74
[3]   Pyruvate kinase M2 is a phosphotyrosine-binding protein [J].
Christofk, Heather R. ;
Vander Heiden, Matthew G. ;
Wu, Ning ;
Asara, John M. ;
Cantley, Lewis C. .
NATURE, 2008, 452 (7184) :181-U27
[4]   Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis [J].
Dombrauckas, JD ;
Santarsiero, BD ;
Mesecar, AD .
BIOCHEMISTRY, 2005, 44 (27) :9417-9429
[5]   Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells [J].
Heiden, Matthew G. Vander ;
Locasale, Jason W. ;
Swanson, Kenneth D. ;
Sharfi, Hadar ;
Heffron, Greg J. ;
Amador-Noguez, Daniel ;
Christofk, Heather R. ;
Wagner, Gerhard ;
Rabinowitz, Joshua D. ;
Asara, John M. ;
Cantley, Lewis C. .
SCIENCE, 2010, 329 (5998) :1492-1499
[6]   Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation [J].
Heiden, Matthew G. Vander ;
Cantley, Lewis C. ;
Thompson, Craig B. .
SCIENCE, 2009, 324 (5930) :1029-1033
[7]   Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase [J].
Jiang, Jian-kang ;
Boxer, Matthew B. ;
Vander Heiden, Matthew G. ;
Shen, Min ;
Skoumbourdis, Amanda P. ;
Southall, Noel ;
Veith, Henrike ;
Leister, William ;
Austin, Christopher P. ;
Park, Hee Won ;
Inglese, James ;
Cantley, Lewis C. ;
Auld, Douglas S. ;
Thomas, Craig J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (11) :3387-3393
[8]  
Kenzaburo T., 1988, GENE, V73, P509
[9]   The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes [J].
Levine, Arnold J. ;
Puzio-Kuter, Anna M. .
SCIENCE, 2010, 330 (6009) :1340-1344
[10]   Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 [J].
Luo, Weibo ;
Hu, Hongxia ;
Chang, Ryan ;
Zhong, Jun ;
Knabel, Matthew ;
O'Meally, Robert ;
Cole, Robert N. ;
Pandey, Akhilesh ;
Semenza, Gregg L. .
CELL, 2011, 145 (05) :732-744